HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Robert Bittman Selected Research

N-(N'-phenethylthiocarbamoyl)sphingosine

5/2004Intrinsic cytotoxicity and chemomodulatory actions of novel phenethylisothiocyanate sphingoid base derivatives in HL-60 human promyelocytic leukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Robert Bittman Research Topics

Disease

25Neoplasms (Cancer)
01/2016 - 05/2004
7Prostatic Neoplasms (Prostate Cancer)
05/2014 - 07/2010
6Inflammation (Inflammations)
01/2020 - 11/2007
5Carcinogenesis
06/2015 - 12/2009
5Breast Neoplasms (Breast Cancer)
05/2014 - 05/2004
4Lung Injury
01/2016 - 10/2011
4Atherosclerosis
07/2014 - 03/2010
3Infections
12/2015 - 03/2005
3Virus Diseases (Viral Diseases)
12/2015 - 03/2005
3Colonic Neoplasms (Colon Cancer)
12/2014 - 12/2009
3Multiple Sclerosis
09/2013 - 11/2007
2Meningitis
10/2016 - 12/2010
2Pneumonia (Pneumonitis)
07/2015 - 06/2015
2Acute Lung Injury
03/2014 - 07/2013
2Neoplasm Metastasis (Metastasis)
09/2013 - 08/2006
2Sepsis (Septicemia)
07/2013 - 12/2010
1Emphysema
01/2022
1Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome)
01/2020
1Ventilator-Induced Lung Injury
01/2020
1Hepatitis
01/2020
1Central Nervous System Infections (Central Nervous System Infection)
10/2016
1Disease Progression
01/2016
1Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental)
01/2016
1Glioblastoma (Glioblastoma Multiforme)
01/2016
1Necrosis
07/2015
1Neoplastic Cell Transformation
12/2014
1Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
09/2014
1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (T-ALL)
09/2014
1Hypercholesterolemia
07/2014
1Hyperlipidemias (Hyperlipidemia)
07/2014
1HIV Infections (HIV Infection)
01/2014
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
10/2013
1Hematologic Neoplasms (Hematological Malignancy)
09/2013
1Splenomegaly
09/2013
1LOM type hereditary motor and sensory Neuropathy
09/2013
1Neuralgia (Stump Neuralgia)
09/2013
1Pruritus (Itching)
09/2013

Drug/Important Bio-Agent (IBA)

14sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
01/2016 - 05/2004
12sphingosine kinaseIBA
09/2014 - 10/2010
11Fingolimod Hydrochloride (FTY720)FDA Link
01/2016 - 11/2007
10SphingolipidsIBA
01/2022 - 11/2008
9Pharmaceutical PreparationsIBA
01/2016 - 11/2007
8CeramidesIBA
01/2022 - 05/2004
8Ether (Diethyl Ether)IBA
01/2016 - 03/2004
8SphingosineIBA
09/2014 - 05/2004
7LipidsIBA
01/2016 - 05/2004
7CholesterolIBA
12/2015 - 05/2004
5Proteins (Proteins, Gene)FDA Link
10/2015 - 05/2004
4Sphingosine-1-Phosphate ReceptorsIBA
01/2022 - 07/2013
4Phosphotransferases (Kinase)IBA
09/2014 - 11/2011
4EnzymesIBA
01/2014 - 10/2010
4AndrogensIBA
06/2013 - 10/2010
3Organophosphonates (Phosphonates)IBA
01/2016 - 07/2013
3lysophosphatidic acidIBA
09/2013 - 03/2004
3Protein Isoforms (Isoforms)IBA
04/2013 - 09/2012
2SmokeIBA
01/2022 - 06/2015
2oxidized low density lipoproteinIBA
07/2014 - 03/2004
2Sirolimus (Rapamycin)FDA Link
07/2014 - 09/2012
2edelfosineIBA
05/2014 - 05/2004
2Hormones (Hormone)IBA
05/2014 - 07/2010
2Therapeutic UsesIBA
03/2014 - 11/2007
2Immunologic Factors (Immunomodulators)IBA
09/2013 - 11/2007
2((E)- 3- amino- 5- (4- heptylphenyl)- 3- (hydroxymethyl)pent- 1- enyl)phosphonic acidIBA
06/2013 - 10/2010
2Cytotoxins (Cytolysins)IBA
07/2010 - 05/2004
2Biological ProductsIBA
11/2008 - 05/2008
2GlycosphingolipidsIBA
03/2007 - 05/2004
2Phospholipids (Phosphatides)FDA LinkGeneric
05/2004 - 03/2004
2Antineoplastic Agents (Antineoplastics)IBA
05/2004 - 05/2004
1Phosphates (Orthophosphate)IBA
01/2022
1LR 172IBA
01/2020
1Concanavalin AIBA
01/2020
1Anti-Bacterial Agents (Antibiotics)IBA
10/2016
1platelet activating factor receptorIBA
01/2016
1Glycerol (Glycerine)FDA LinkGeneric
01/2016
1InflammasomesIBA
01/2016
1Platelet Activating FactorIBA
01/2016
1NicotineFDA Link
07/2015
114-3-3 Proteins (14-3-3 Protein)IBA
06/2015
1LyasesIBA
12/2014
1MicroRNAs (MicroRNA)IBA
12/2014
1CytokinesIBA
12/2014
1sphingosine 1-phosphate lyase (aldolase)IBA
12/2014
1LDL Receptors (LDL Receptor)IBA
07/2014
1TOR Serine-Threonine KinasesIBA
07/2014
1Tyrosine (L-Tyrosine)FDA Link
05/2014
1Small Interfering RNA (siRNA)IBA
05/2014
1Estrogen ReceptorsIBA
05/2014
1Calcium-Activated Potassium Channels (Calcium-Activated Potassium Channel)IBA
05/2014
1Phosphorus (Red Phosphorus)IBA
05/2014
11- O- (7'- N,N- dimethylamino- 3'- pentadecanoyl- 1'- naphthyl)- 2- O- methyl- sn- glycerophosphocholineIBA
05/2014
1MonosaccharidesIBA
05/2014
1DisaccharidesIBA
05/2014
12- amino- 2- (2- (4- octylphenyl)ethyl)propane- 1,3- diol phosphonateIBA
03/2014
1Bleomycin (Blenoxane)FDA LinkGeneric
03/2014
1VaccinesIBA
01/2014
1Tyrosine Kinase InhibitorsIBA
10/2013
1Immunosuppressive Agents (Immunosuppressants)IBA
09/2013
1alkylglycerophosphoethanolamine phosphodiesteraseIBA
09/2013

Therapy/Procedure

8Therapeutics
01/2020 - 04/2013
1Oral Administration
12/2014